Use tumor suppressor genes as biomarkers for diagnosis of non-small cell lung cancer
Abstract Lung cancer is the leading cause of death worldwide. Especially, non-small cell lung cancer (NSCLC) has higher mortality rate than the other cancers. The high mortality rate is partially due to lack of efficient biomarkers for detection, diagnosis and prognosis. To find high efficient bioma...
Main Authors: | Chuantao Zhang, Man Jiang, Na Zhou, Helei Hou, Tianjun Li, Hongsheng Yu, Yuan-De Tan, Xiaochun Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-80735-x |
Similar Items
-
ALK rearrangements as mechanisms of acquired resistance to osimertinib in EGFR mutant non‐small cell lung cancer
by: Helei Hou, et al.
Published: (2021-03-01) -
Genetic Profile of Young Chinese Patients with Lung Adenocarcinoma
by: Yu LIANG, et al.
Published: (2020-04-01) -
Effect and biomarker of immune checkpoint blockade therapy for ARID1A deficiency cancers
by: Li Wang, et al.
Published: (2020-10-01) -
Chemotherapy Alters the Phylogenetic Molecular Ecological Networks of Intestinal Microbial Communities
by: Jing Cong, et al.
Published: (2019-05-01) -
The role of MDM2 amplification and overexpression in therapeutic resistance of malignant tumors
by: Helei Hou, et al.
Published: (2019-08-01)